Delivery Order SPE2DB20D2014-SPE2DB24FB57R
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DOVATO 50-300 MG TABLET 30S. The contract has a firm fixed price, a ceiling value of $13,718.33, and an ultimate completion date of May 16, 2025. The contract is not set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,462.73, is for the delivery of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. The contract is a firm-fixed price delivery order, with an ultimate completion date of April 28, 2025. It is not set aside for any particular business type. AmerisourceBergen Drug Corp is the prime...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. The contract has a potential value of $8,450.92 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and holds an indefinite delivery contract (IDC) with DLA with a potential value...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DOVATO 50-300 MG TABLET 30S. The contract has a ceiling value of $9,766.37 and is a firm fixed-price, non-set-aside contract type with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $65,608.79 and a performance period through February 26, 2024. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a broader Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,918.58, is for the delivery of the pharmaceutical product DOVATO 50-300 MG TABLET 30S. The contract has an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,775.41, is for the delivery of the pharmaceutical product DOVATO 50-300 MG TABLET 30S. The contract is a firm fixed-price, non-set-aside award with a performance period ending on April 29, 2025. AmerisourceBergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,734.00, is for the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of March 13, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DOVATO 50-300 MG TABLET 30S, with an ultimate completion date of July 9, 2025 and a ceiling value of $25,122.66. This contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $40,382.37 contract is for the supply of the pharmaceutical product DOVATO 50-300 MG TABLET 30S. The contract has a Firm Fixed Price pricing type and an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract without any set-aside designation. The company...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB57RDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product, over a 3-year period ending in April 2024. The contract has a firm fixed price of $8,343.59 and is not set aside for any specific business type. Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, is the prime contractor and will fulfill the order from its extensive supply chain network. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 4/10/24 |